Type
1.
Queiroz EA, Medeiros NI, Mattos RT, Pinto BF, Carvalho APM, Dutra WO, et al. CCL2 and IFN-γ serum levels as biomarker for subclinical infection in household contacts of leprosy patients. Microbial pathogenesis. 2021;:104725.
Type
1.
Khadilkar S, Patil SB, Shetty VP. Neuropathies of leprosy. Journal of the neurological sciences. 2020;420:117288.
Type
1.
Abbade LPF, Cipriani Frade M, Pegas JRP, Dadalti-Granja P, Garcia LC, Filho RB, et al. Consensus on the diagnosis and management of chronic leg ulcers - Brazilian Society of Dermatology. Anais brasileiros de dermatologia [Internet]. 2020;95 Suppl 1:1-18. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772605/pdf/main.pdf
Type
1.
Chae GT. Modern History of Hansen’s Disease in Korea. Infection & chemotherapy [Internet]. 2020;52(4):647-53. Available from: https://www.icjournal.org/pdf/10.3947/ic.2020.52.4.647
Type
1.
Marçal PHF, Gama RS, de Oliveira LBP, Martins-Filho OA, Pinheiro RO, Sarno EN, et al. Functional biomarker signatures of circulating T-cells and its association with distinct clinical status of leprosy patients and their respective household contacts. Infectious diseases of poverty [Internet]. 2020;9(1):167. Available from: https://idpjournal.biomedcentral.com/articles/10.1186/s40249-020-00763-7
Type
1.
Mohta A, Agrawal A, Sharma P, Singh A, Garg S, Kushwaha RK, et al. Endocrinological Testicular Dysfunction in Patients with Lepromatous Leprosy and the Impact of Disease on Patient’s Quality of Life. Indian dermatology online journal [Internet]. 2020;11(6):959-64. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735009/
Type
1.
Theunuo R, Sasidharanpillai S, Ajithkumar K, George B Department of Community Medicine, Government Medical College, Kozhikode, Kerala, India, Salim RS. Nail Changes in Leprosy: Onychoscopy Evaluation. Indian dermatology online journal [Internet]. 2020;11(6):970-4. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734986/
Type
1.
Gunawan H, Nursjamsi NCD, Achdiat PA, Suwarsa O. Reactive perforating leprosy: A rare case report of type 2 leprosy reaction. International journal of mycobacteriology [Internet]. 2020;9(4):451-3. Available from: https://www.ijmyco.org/temp/IntJMycobacteriol94451-3612323_100203.pdf
Type
1.
Saxena S, Khurana A, B S, Sardana K, Agarwal A, Muddebihal A, et al. Severe Type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Internet]. 2020; Available from: https://www.ijidonline.com/article/S1201-9712(20)32547-9/pdf
Type
1.
van Dijk HM, van Hooij A, Groot M, Geboers J, Moretti R, Verhard-Seymonsbergen E, et al. Synthetic Phenolic Glycolipids for application in diagnostic tests  for leprosy. Chembiochem : a European journal of chemical biology. 2020;